Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 5
2005 7
2006 5
2007 21
2008 11
2009 8
2010 17
2011 18
2012 24
2013 18
2014 33
2015 25
2016 23
2017 22
2018 25
2019 26
2020 31
2021 27
Text availability
Article attribute
Article type
Publication date

Search Results

307 results
Results by year
Filters applied: . Clear all
Page 1
Secondary IgA nephropathy.
Saha MK, Julian BA, Novak J, Rizk DV. Saha MK, et al. Among authors: novak j. Kidney Int. 2018 Oct;94(4):674-681. doi: 10.1016/j.kint.2018.02.030. Epub 2018 May 24. Kidney Int. 2018. PMID: 29804660 Free PMC article. Review.
Glycosylation in health and disease.
Reily C, Stewart TJ, Renfrow MB, Novak J. Reily C, et al. Among authors: novak j. Nat Rev Nephrol. 2019 Jun;15(6):346-366. doi: 10.1038/s41581-019-0129-4. Nat Rev Nephrol. 2019. PMID: 30858582 Free PMC article. Review.
IgA nephropathy.
Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ. Lai KN, et al. Among authors: novak j. Nat Rev Dis Primers. 2016 Feb 11;2:16001. doi: 10.1038/nrdp.2016.1. Nat Rev Dis Primers. 2016. PMID: 27189177 Review.
The pathophysiology of IgA nephropathy.
Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA. Suzuki H, et al. Among authors: novak j. J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23. J Am Soc Nephrol. 2011. PMID: 21949093 Free PMC article. Review.
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P. Wei AH, et al. Among authors: novak j. Blood. 2020 Jun 11;135(24):2137-2145. doi: 10.1182/blood.2020004856. Blood. 2020. PMID: 32219442 Free PMC article. Clinical Trial.
Muscle-specific microRNAs in skeletal muscle development.
Horak M, Novak J, Bienertova-Vasku J. Horak M, et al. Among authors: novak j. Dev Biol. 2016 Feb 1;410(1):1-13. doi: 10.1016/j.ydbio.2015.12.013. Epub 2015 Dec 19. Dev Biol. 2016. PMID: 26708096 Free article. Review.
Markers for the progression of IgA nephropathy.
Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. Maixnerova D, et al. Among authors: novak j. J Nephrol. 2016 Aug;29(4):535-41. doi: 10.1007/s40620-016-0299-0. Epub 2016 May 3. J Nephrol. 2016. PMID: 27142988 Free PMC article. Review.
Caffeine and cardiovascular diseases: critical review of current research.
Zulli A, Smith RM, Kubatka P, Novak J, Uehara Y, Loftus H, Qaradakhi T, Pohanka M, Kobyliak N, Zagatina A, Klimas J, Hayes A, La Rocca G, Soucek M, Kruzliak P. Zulli A, et al. Among authors: novak j. Eur J Nutr. 2016 Jun;55(4):1331-43. doi: 10.1007/s00394-016-1179-z. Epub 2016 Mar 1. Eur J Nutr. 2016. PMID: 26932503 Review.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Samoilova O, Novak J, Ben-Yehuda D, Strugov V, Gill D, Gribben JG, Hsu E, Lih CJ, Zhou C, Clow F, James DF, Styles L, Flinn IW. Moreno C, et al. Among authors: novak j. Lancet Oncol. 2019 Jan;20(1):43-56. doi: 10.1016/S1470-2045(18)30788-5. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522969 Clinical Trial.
307 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page